Morrison & Foerster

International top 30 position: 30
Asia-Pacific International 50 rank: 13

China life sciences newsletter — Winter 2012

Welcome to the Fall/Winter 2012 issue of our China Life Sciences Newsletter, a periodic update on key developments, companies, and people in the dynamic China life sciences industry. In this issue, we bring you an interview with Dr. Dan Zhang, Founder and CEO of Fountain Medical Development, a full-service clinical CRO, based in South East Asia and China; the second of a three-part series discussing the strategic partnerships between Western and Chinese companies for the purpose of conducting early-stage pharma and biotech R&D (please find the first part in our Spring Issue); an analysis of compulsory patent licensing practices in China; and a discussion of new developments on the “patentable subject matter” requirement of U.S. patent law.

Click on the link above to download this Morrison & Foerster briefing.

Briefings from Morrison & Foerster

View more briefings from Morrison & Foerster

Browse This Firm’s

Overview

CityPoint
1 Ropemaker Street
London
EC2Y 9AW
UK

Global revenue 2011 ($m): 963.3
Global lawyers 2011: 1,026
No. of lawyers (Asia Pacific): 168
Offices (Asia Pacific): 5